A trial comparing Metvix photodynamic therapy [methyl aminolevulinate] followed by Mohs micrographic surgery against Mohs micrographic surgery alone for the treatment of basal cell carcinoma
Phase of Trial: Phase II
Latest Information Update: 28 Jan 2010
At a glance
- Drugs Methyl aminolevulinate (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 28 Jan 2010 Status changed from not stated to completed as reported by ClinicalTrials.gov.
- 28 Oct 2006 New trial record.